MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10741-023-10342-1

Медицинская библиотека · Heart failure reviews · 2023

The role and medical prospects of long non-coding RNAs in cardiovascular disease.

Kim Najung, Chung Woo-Young, Cho Je-Yoel

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Cardiovascular disease (CVD) has reached epidemic proportions and is a leading cause of death worldwide. One of the long-standing goals of scientists is to repair heart tissue damaged by various forms of CVD such as cardiac hypertrophy, dilated cardiomyopathy, myocardial infarction, heart fibrosis, and genetic and developmental heart defects such as heart valve deformities. Damaged or defective heart tissue has limited regenerative capacity and results in a loss of functioning myocardium. Advances in transcriptomic profiling technology have revealed that long noncoding RNA (lncRNA) is transcribed from what was once considered "junk DNA." It has since been discovered that lncRNAs play a critical role in the pathogenesis of various CVDs and in myocardial regeneration. This review will explore how lncRNAs impact various forms of CVD as well as those involved in cardiomyocyte regeneration. Further, we discuss the potential of lncRNAs as a therapeutic modality for treating CVD.

Для цитирования: Kim Najung, Chung Woo-Young, Cho Je-Yoel. The role and medical prospects of long non-coding RNAs in cardiovascular disease.. Heart failure reviews. 2023. DOI: 10.1007/s10741-023-10342-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.